---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-036076"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2025-11-24T23:59:59+00:00"
generated_at: "2026-05-16T17:30:43.574495+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# BioCardia appoints Farhan Shahab as VP of Quality

## Summary
- Farhan Shahab named Vice President of Quality, effective November 24, 2025.
- Shahab brings over 25 years of experience in quality and regulatory roles at Medtronic, AngioScore, and Welldoc.
- CEO Peter Altman says Shahab's expertise will accelerate commercialization of investigational products.
- Shahab holds a BS in Chemical Engineering from UMass and an MBA from University of Phoenix.
- He is Regulatory Affairs Certified (RAC) and Certified Auditor (Exemplar Global).

## SEC filing metadata
- accession: 0001437749-25-036076
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2025-11-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774925036076/0001437749-25-036076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774925036076/bcda20251121_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-036076
- JSON: https://secwatch.observer/filing/0001437749-25-036076.json
- Plain text: https://secwatch.observer/filing/0001437749-25-036076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.